Patents by Inventor Wayne S. Maxson

Wayne S. Maxson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5215531
    Abstract: The present invention provides a device for immobilizing a cannula or sheath which is inserted into a patient's body in a laparoscopic surgical procedure. The device comprises a cannula skirt through which the cannula passes. The skirt contains a leakage cavity therein which is configured to minimize the pull-off forces which would tend to cause a separation of the skirt from the skin to which it is adhered during the surgical procedure. In addition, the leakage cavity provides enhanced flexibility to the cannula skirt so that the cannula can be angled during the procedure without causing excessive stress on the adhesive. A ratchet ring clamp is also provided on the cannula skirt to constrict the cannula skirt and thereby immobilize the cannula after the cannula has been inserted through the skirt.
    Type: Grant
    Filed: June 25, 1992
    Date of Patent: June 1, 1993
    Assignee: Lap Associates of Nashville II
    Inventors: Wayne S. Maxson, Stephen Chakoff
  • Patent number: 5140021
    Abstract: A pharmaceutical composition suitable for oral administration comprises micronized progesterone in an oil vehicle which is high in glycerides of polyunsaturated fatty acids. Micronized progesterone particles suspended in such an oil vehicle are absorbed more readily into the bloodstream and achieve high progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of premenstrual syndrome.
    Type: Grant
    Filed: October 27, 1989
    Date of Patent: August 18, 1992
    Assignee: Genesis Systems Corporation
    Inventors: Wayne S. Maxson, Joel T. Hargrove, Philip G. Meyers
  • Patent number: 4963540
    Abstract: A pharmaceutical composition suitable for oral administration comprises micronized progesterone in an oil vehicle which is high in glycerides of polyunsaturated fatty acids. Micronized progesterone particles suspended in such an oil vehicle are absorbed more readily into the bloodstream and achieve high progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of premenstrual syndrome.
    Type: Grant
    Filed: January 13, 1988
    Date of Patent: October 16, 1990
    Inventors: Wayne S. Maxson, Joel T. Hargrove, Philip G. Meyers
  • Patent number: 4900734
    Abstract: A pharmaceutical composition is provided for oral administration. The composition comprises estradiol dissolved in an oil vehicle containing a suspension of micronized progesterone. The oil vehicle is high in glycerides of polyunsaturated fatty acids. The estradiol and micronized progesterone contained in the oil are more readily absorbable in the blood stream and achieve enhanced estradiol and progesterone blood serum levels. The pharmaceutical composition according to the invention can be readily formulated into capsules and administered for the treatment of menopausal symptoms.
    Type: Grant
    Filed: August 27, 1987
    Date of Patent: February 13, 1990
    Inventors: Wayne S. Maxson, Joel T. Hargrove, Joe H. Delk